Investigation of Several Biomarkers Associated with Diabetic Nephropathy

Abstract

Objective: The aim of this study was to facilitate the systematic discovery of diagnostic biomarkers of diabetic nephropathy (DN).

Methods: 3 publicly available independent cohorts were got from Gene Expression Omnibus database. Gene expression array were used to screen for genome-wide relative significance (GWRS) and genome-wide global significance (GWGS). The most significant up- and down-regulated top 100 gene signatures were identified using a fold change based model. Then the protein-protein interaction (PPI) network was constructed, while the hub genes in this PPI network were identified by centrality analysis. Modules detection was performed to explore the functions of the modules. Meanwhile, gene enrichment analysis was performed to illuminate the biological pathways and processes associated with DN.

Results: The most significant up- and down-regulated top 100 gene signatures were identified and a PPI network was established. Several hub genes (VEGFA, IL8, MYC, CD14, ALB) were discovered. Several functional modules were revealed. Biological pathways including cytokine-cytokine receptor interaction and p53 signaling pathway, and processes including inflammatory response, response to wounding and enzyme linked receptor protein signaling pathway were identified.

Conclusion: Our study displayed underlying biomarkers including biological pathways and several hub genes of DN.

Key words

diabetic nephropathy - hub genes - bioinformatics

• References

• 1 Bell CG, Teschendorff AE, Rakyan VK et al. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 2010; 3: 33
• 2 Inoki K, Mori H, Wang J et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 2011; 121: 2181-2196
• 3 Oudit GY, Liu GC, Zhong J et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 2010; 59: 529-538
• 4 Hovind P, Rossing P, Johnson RJ et al. Serum uric acid as a new player in the development of diabetic nephropathy. J Renal Nutr 2011; 21: 124-127
• 5 Barrett T, Troup DB, Wilhite SE et al. NCBI GEO: archive for functional genomics data sets – 10 years on. Nucleic Acids Res 2011; 39: 1005-1010
• 6 Parkinson H, Kapushesky M, Shojatalab M et al. ArrayExpress – a public database of microarray experiments and gene expression profiles. Nucleic Acids Res 2007; 35: 747-750
• 7 Schramm SJ, Campain AE, Scolyer RA et al. Review and cross-validation of gene expression signatures and melanoma prognosis. J Invest Dermatol 2012; 132: 274-283
• 8 Timar J, Gyorffy B, Raso E. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?. Clin Exp Metastas 2010; 27: 371-387
• 9 Baelde HJ, Eikmans M, Doran PP et al. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 2004; 43: 636-650
• 10 Woroniecka KI, Park AS, Mohtat D et al. Transcriptome analysis of human diabetic kidney disease. Diabetes 2011; 60: 2354-2369
• 11 Liu W, Peng Y, Tobin DJ. A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis. PeerJ 2013; 1: e49
• 12 Szklarczyk D, Franceschini A, Kuhn M et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011; 39: 561-568
• 13 Cline MS, Smoot M, Cerami E et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007; 2: 2366-2382
• 14 Scardoni G, Laudanna C. Centralities based analysis of complex networks. New Frontiers in Graph Theory InTech Open 2012
• 15 Da Wei Huang BTS, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2008; 4: 44-57
• 16 McCarthy DJ, Smyth GK. Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 2009; 25: 765-771
• 17 Yanofsky CM, Bickel DR. Validation of differential gene expression algorithms: Application comparing fold-change estimation to hypothesis testing. BMC Bioinformatics 2010; 11: 63
• 18 Kadota K, Nakai Y, Shimizu K. A weighted average difference method for detecting differentially expressed genes from microarray data. Algorithms Mol Biol 2008; 3: 8
• 19 Farztdinov V, McDyer F. Distributional fold change test – a statistical approach for detecting differential expression in microarray experiments. Algorithms Mol Biol 2012; 7: 29
• 20 Chang W, Ma L, Lin L et al. Identification of novel hub genes associated with liver metastasis of gastric cancer. Int J Cancer 2009; 125: 2844-2853
• 21 Peng W, Wang J, Cai J et al. Improving protein function prediction using domain and protein complexes in PPI networks. BMC Syst Biol 2014; 8: 35
• 22 Wright SD, Ramos RA, Tobias PS et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433
• 23 Baumann CL, Aspalter IM, Sharif O et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med 2010; 207: 2689-2701
• 24 Devitt A, Moffatt OD, Raykundalia C et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998; 392: 505-509
• 25 Fernández-Real JM, Del Pulgar SP, Luche E et al. CD14 modulates inflammation-driven insulin resistance. Diabetes 2011; 60: 2179-2186
• 26 Andia DC, Letra A, Casarin RCV et al. Genetic analysis of the IL8 gene polymorphism (rs4073) in generalized aggressive periodontitis. Arch Oral Biol 2013; 58: 211-217
• 27 Singh JK, Simões BM, Howell SJ et al. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res 2013; 15: 210
• 28 He T-C, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-1512
• 29 Hermeking H, Rago C, Schuhmacher M et al. Identification of CDK4 as a target of c-MYC. P Natl A Sci 2000; 97: 2229-2234
• 30 Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Bio 2005; 6: 635-645
• 31 Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nature Reviews Cancer 2008; 8: 976-990
• 32 Hirakawa S, Kodama S, Kunstfeld R et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005; 201: 1089-1099
• 33 Rydén L, Stendahl M, Jonsson H et al. Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response. Breast Cancer ResTr 2005; 89: 135-143
• 34 Terme M, Pernot S, Marcheteau E et al. VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer. Cancer Res 2013; 73: 539-549